Posted on February 11, 2010.
Ovarian cancer has been diagnosed you? Two percent of newborns of women in the United States are at risk of contracting ovarian cancer
Like many women of 30,000 will be diagnosed with ovarian cancer this year. In 2006, women between 15,000 and 16,000 may die from this silent killer. Ovarian cancer is the fifth leading cause of death among women, and is responsible for approximately five percent of cancer deaths. Chances are your doctor may have you confused. Is often the case. A recent British study found 60 percent of all practitioners in the United Kingdom General had confused with their patients. Three quarters of British doctors surveyed incorrectly assumed that the symptoms occurred in the late stages of ovarian cancer. Based on this information, it should not be surprising that Great Britain has one of the lowest survival rates for ovarian cancer in the Western world - 6,800 cases diagnosed each year, more than 4,600 deaths.
A similar discovery was made by researchers at the University of California, who announced last year, "Four in 10 women with ovarian cancer have symptoms that they tell their doctor at least four months - and as long as a year - before they are diagnosed. According to their study of nearly 2,000 women with ovarian cancer, researchers have found doctors:
aec First ranked abdominal imaging or gastrointestinal procedures are carried out instead of more appropriate pelvic imaging and / or CA-125 (a blood test to detect ovarian cancer).
aec Only 25 percent of patients who reported symptoms of ovarian cancer four months or more before diagnosis, received pelvic imaging or CA-125 had blood tests.
Patients with early symptoms are often misdiagnosed. Abdominal imaging or diagnostic gastrointestinal studies are less likely to detect cancer of the ovary. According to the website of the American Cancer Society, "The most common symptom is back pain, followed by fatigue, bloating, constipation, abdominal pain and urinary urgency. These symptoms tend to occur very frequently and become more severe over time. Most women with ovarian cancer have at least two of these symptoms. "
When a woman is the fourth stage of ovarian cancer, its treatment is often the first line carboplatin, paclitaxel and cisplatin chemotherapy for ovarian cancer. Initially, the cancer is contained in one or both ovaries. In the second stage, the cancer has spread to the fallopian tubes or other pelvic tissues, such as the bladder or rectum. When the cancer has spread beyond the pelvis into the abdominal cavity, especially when tumor growths are more than two inches from the wall of the abdomen and ovarian cancer has reached the third stage. The fourth and final stage of ovarian cancer is reached when the cancer has spread to other organs of the body, such as liver or lungs.
If detected early, survival rates can be as high as 90 percent. Detected at an advanced stage, the survival rate drops to between 30 and 40 per cent. Various imaging tests such as computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound can confirm whether a pelvic mass is present. A laparoscopy may help a doctor to examine the ovaries and other pelvic tissues input to plan surgery, or to determine the stage of ovarian cancer. A biopsy or tissue samples, to confirm whether cancer in your pelvic area, and help determine how advanced it is. A blood test CA-125 level generally indicates that the cancer has progressed to an advanced stage.
About 50 percent of patients with ovarian cancer are already at an advanced stage when a correct diagnosis. Only 10-14 percent of women with advanced cancer are likely to survive more than five years.
Therapy Evaluation
Although research shows drinking bl.
